Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Neurogait
Neurogait Overview
Neurogait is developing a clinical monitoring platform for neurodegenerative movement disorders such as Parkinson's for Pharmaceuticals and Hospital clinics. . It uses digital biological markers and AI to track disease symptoms and drug affects enabling 24/7 patient data.
The company is running clinical trials in Sheba medical center and has signed a strategic partnership with Sheba via its ARC innovation team. It is also in conversation with major Pharmaceuticals to engage in joined pilots in to test out its platform in 2024.